Skip to main content

. 1977 Mar;59(3):456P–457P.

Reversal of morphine-induced suppression of active avoidance behaviour by the tetracyclic antidepressant mianserin [proceedings].

E Preston, H Rigter, C Strijbos, E Schönbaum

PMCID: PMC1668008 PMID: 843702

456P

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

VERHAVE T., OWEN J. E., Jr, ROBBINS E. B. The effect of morphine sulfate on avoidance and escape behavior. J Pharmacol Exp Ther. 1959 Mar;125(3):248–251. [PubMed] [Google Scholar]
Vargaftig B. B., Coignet J. L., de Vos C. J., Grijsen H., Bonta I. L. Mianserin hydrochloride: peripheral and central effects in relation to antagonism against 5-hydroxytryptamine and tryptamine. Eur J Pharmacol. 1971 Nov-Dec;16(3):336–346. doi: 10.1016/0014-2999(71)90036-7. [DOI] [PubMed] [Google Scholar]
Wheatley D. Controlled clinical trial of a new antidepressant (Org. GB 94) of novel chemical formulation. Curr Ther Res Clin Exp. 1975 Dec;18(6):849–854. [PubMed] [Google Scholar]
Yaksh T. L., DuChateau J. C., Rudy T. A. Antagonism by methysergide and cinanserin of the antinociceptive action of morphine administered into the periaqueductal gray. Brain Res. 1976 Mar 12;104(2):367–372. doi: 10.1016/0006-8993(76)90634-x. [DOI] [PubMed] [Google Scholar]
van Riezen H. Different central effects of the 5-HT antagonists mianserine and cyproheptadine. Arch Int Pharmacodyn Ther. 1972 Aug;198(2):256–269. [PubMed] [Google Scholar]

ACTIONS

PDF (316.2 KB)

RESOURCES